Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Asian Studies (22)
- International and Area Studies (22)
- Behavioral Economics (8)
- Gerontology (7)
- Medicine and Health Sciences (7)
-
- Sociology (7)
- Public Health (5)
- Econometrics (4)
- Emergency and Disaster Management (3)
- Income Distribution (3)
- Public Affairs, Public Policy and Public Administration (3)
- Industrial Organization (2)
- Labor Economics (2)
- Business (1)
- Chemicals and Drugs (1)
- Family, Life Course, and Society (1)
- Finance (1)
- Growth and Development (1)
- Health Policy (1)
- Health and Medical Administration (1)
- Life Sciences (1)
- Medicine and Health (1)
- Nutrition (1)
- Public Economics (1)
- Technology and Innovation (1)
- Keyword
-
- COVID-19 (6)
- Singapore (5)
- Cambodia (4)
- China (4)
- Health (4)
-
- Health inequality (4)
- Health insurance (4)
- Malnutrition (4)
- Small-area estimation (4)
- Pandemic (3)
- Agglomeration (2)
- Attitudes (2)
- Bias (2)
- Child mortality rate (2)
- China Famine (2)
- Consumption (2)
- Demographic and Health Surveys (2)
- Elderly (2)
- Government effectiveness (2)
- Health care (2)
- Health spending (2)
- Life expectancy at birth (2)
- Life satisfaction (2)
- Malawi (2)
- Massachusetts healthcare reform (2)
- Measures (2)
- Missing data (2)
- Non-response (2)
- Refusals (2)
- Subjective well-being (2)
- Publication Year
- Publication
- Publication Type
Articles 61 - 69 of 69
Full-Text Articles in Health Economics
Gene Patenting In The Life Sciences Industry: Boon Or Bane?, Knowledge@Smu
Gene Patenting In The Life Sciences Industry: Boon Or Bane?, Knowledge@Smu
Knowledge@SMU
Does gene patenting encourage or hinder knowledge diffusion and take-up in the life sciences industry? Research by Singapore Management University management professor Kenneth Huang, and Massachusetts Institute of Technology management professor Fiona Murray found that patenting can have a negative impact on scientific progress. Huang spoke to Knowledge@SMU about the implications of his research findings in the Singapore context.
Geographic Decomposition Of Inequality In Health And Wealth: Evidence From Cambodia, Tomoki Fujii
Geographic Decomposition Of Inequality In Health And Wealth: Evidence From Cambodia, Tomoki Fujii
Research Collection School Of Economics
The small-area estimation developed by Elbers, Lanjouw and Lanjouw (2002, 2003), in which a census and a survey are combined to produce the estimates of welfare measures for small geographic areas, has become a standard tool for poverty analysis in developing countries. The small-area estimates are typically plotted on a map, which are commonly called a poverty map. Poverty maps proved useful for policy analysis and formulation, and have become increasingly popular among policy-makers and researchers. In Cambodia, poverty maps have been used by various international organizations, ministries and non-governmental organizations for analyzing the poverty situations for their operation areas, …
The Business Of Healthcare: A Slippery Slope?, Knowledge@Smu
The Business Of Healthcare: A Slippery Slope?, Knowledge@Smu
Knowledge@SMU
In Singapore, healthcare consumes 3.7% of GDP and is rising. Jeremy Lim, director of policy and research at Singapore Health Services (SingHealth), was the featured speaker at a recent Singapore Management University Wee Kim Wee Centre event. Lim trained as a surgeon before moving into healthcare management and health services research. He talked to Knowledge@SMU about the business opportunities and challenges in Singapore’s healthcare sector.
How Doctors And Patients Get Better, Knowledge@Smu
How Doctors And Patients Get Better, Knowledge@Smu
Knowledge@SMU
In Better: A Surgeon's Notes on Performance, Atul Gawande, a surgeon who also is a staff writer for The New Yorker magazine, examines both the utilitarian and the human sides of medical practice. In the book, he examines what goes right in American medical care, what goes wrong, how things either succeed or fail, and what might be done to improve the system. Among the examples he provides: A polio "mop up" in Karnataka, where Indian health care workers deployed 37,000 vaccinators to immunize 4 million children – in three days.
Novartis's Alex Gorsky: Ensuring That Patients Get Access To The Medicines They Need, Knowledge@Smu
Novartis's Alex Gorsky: Ensuring That Patients Get Access To The Medicines They Need, Knowledge@Smu
Knowledge@SMU
Alex Gorsky was named head of Pharma North America and CEO of Novartis Pharmaceuticals Corp., the U.S. affiliate of Swiss drug giant Novartis, in the fall of 2005. Since joining the company in 2004 as chief operating officer and head of general medicines, Gorsky has overseen the continued growth of Novartis's industry-leading cardiovascular franchise, notably the blockbuster drugs Diovan and Lotrel. The company sells a variety of products, including those that treat endocrine and respiratory disease, gastrointestinal illnesses, cancer and blood disorders and bone and joint conditions, among others. Prior to joining Novartis, Gorsky was company group chairman for Johnson …
Can't Afford To See A Doctor? The Difficulties Of Reforming China's Healthcare System, Knowledge@Smu
Can't Afford To See A Doctor? The Difficulties Of Reforming China's Healthcare System, Knowledge@Smu
Knowledge@SMU
An article co-published on May 22 by China Social Science Literature Publishing house and China Medical Industry Magazine, entitled “Healthcare Greenpaper,” reviews a series of problems associated with China’s healthcare reform over the past 10 years. Of the five biggest problems identified by the paper, the worst one is prohibitively expensive treatment. To examine this issue, Knowledge@Wharton interviewed a variety of experts and officials on the state of health care in China and the changing relationships between hospitals and patients.
Industry Leaders Debate Big Pharma R&D (Too Little Hope?) And Stem Cell Research (Too Much Hype?), Knowledge@Smu
Industry Leaders Debate Big Pharma R&D (Too Little Hope?) And Stem Cell Research (Too Much Hype?), Knowledge@Smu
Knowledge@SMU
Different points on the research spectrum were under the microscope at the Wharton Health Care Business Conference last month as two panels of biotech, pharmaceutical and investment leaders discussed the state of R&D among big pharmaceuticals and the progress of stem cell research. While disappointing results in both sectors have dominated the news lately, panelists at each session also noted some promising developments -- and causes for optimism -- in their respective fields.
Micro-Level Estimation Of Child Malnutrition Indicators And Its Application In Cambodia, Tomoki Fujii
Micro-Level Estimation Of Child Malnutrition Indicators And Its Application In Cambodia, Tomoki Fujii
Research Collection School Of Economics
One of the major limitations in addressing child malnutrition is lack of information that could be used to target resources. By combining demographic and health survey (DHS) and population census data, the author disaggregates the estimates of the prevalence of child malnutrition in Cambodia from currently available 17 DHS strata into 1,594 communes. The methodology is built on the small-area estimation technique developed by Elbers, Lanjouw, and Lanjouw. The author extends it to jointly estimate multiple indicators and to allow for a richer structure of error terms. Average standard errors for the commune-level estimates in this study were about 4 …
Comment: A Selective Overview Of Nonparametric Methods In Financial Econometrics, Peter C. B. Phillips, Jun Yu
Comment: A Selective Overview Of Nonparametric Methods In Financial Econometrics, Peter C. B. Phillips, Jun Yu
Research Collection School Of Economics
These comments concentrate on two issues arising from Fan’s overview. The first concerns the importance of finite sample estimation bias relative to the specification and discretization biases that are emphasized in Fan’s discussion. Past research and simulations given here both reveal that finite sample effects can be more important than the other two effects when judged from either statistical or economic viewpoints. Second, we draw attention to a very different nonparametric technique that is based on computing an empirical version of the quadratic variation process. This technique is not mentioned by Fan but has many advantages and has accordingly attracted …